🇺🇸 LLY — Eli Lilly and Company

Salud Compra
← Volver

Precio actual

1.409,38 USD

Máx. histórico

1.417,54

4 días

Split 2:1 del 16/10/1997

Caída desde máximo

-0,58%

Rango 52 semanas

850,51 – 1.449,68

Variación hoy

-0,11%

Cierre anterior

1.410,99

Rango de hoy

1.393,61 – 1.437,00

Volumen hoy

2.713.999

Peor caída histórica

-68,26%

08/08/2000 → 05/03/2009

Recuperado en 2064 días

Volatilidad anualizada ⓘ

27,61%

Información
Nombre completo
Eli Lilly and Company
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
50.000
PER ⓘ
45,74 (puede no estar actualizado)
Dividend yield
0,49% (puede no estar actualizado)
Precio objetivo analistas
1.442,09 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 21 horas
Sobre la empresa

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss; Olumiant; Omvoh; and Taltz. Further, it provides Emgality for migraine prevention and episodic cluster headache; and Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; BioArctic AB (publ) for new treatment; QurCan Therapeutics Inc for development of PLNP-enabled genetic medicine therapeutics for the treatment of central nervous system and peripheral nervous system; and Abbisko Therapeutics for discovery and development of medicines across multiple targets. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Dividendos repartidos Total últimos 12 meses: 6,6900 USD · Yield: 0,47%
Fecha de pago Importe por participación
14/08/2026 1,7300 USD
15/05/2026 1,7300 USD
13/02/2026 1,7300 USD
14/11/2025 1,5000 USD
15/08/2025 1,5000 USD
16/05/2025 1,5000 USD
14/02/2025 1,5000 USD
15/11/2024 1,3000 USD
15/08/2024 1,3000 USD
15/05/2024 1,3000 USD
14/02/2024 1,3000 USD
14/11/2023 1,1300 USD
14/08/2023 1,1300 USD
12/05/2023 1,1300 USD
14/02/2023 1,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
16/10/1997 2:1
21/12/1995 2:1
01/05/1989 2:1
30/01/1986 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/01/2022 246,88 247,88 242,12 243,06 -0,03% 2,33% 2.788.600
20/01/2022 245,58 247,95 242,50 243,13 -0,78% 2,22% 2.655.400
19/01/2022 246,33 250,41 244,73 245,05 -0,82% 2,31% 2.487.600
18/01/2022 242,75 248,52 242,09 247,07 +1,21% 2,65% 3.241.200
14/01/2022 250,15 250,54 242,90 244,12 -2,22% 3,05% 2.894.300
13/01/2022 254,07 255,50 248,55 249,67 -2,44% 2,74% 3.726.500
12/01/2022 252,90 257,44 250,97 255,92 -2,44% 2,56% 6.562.800
11/01/2022 261,59 262,41 257,06 262,32 +0,85% 2,05% 2.294.000
10/01/2022 258,19 260,16 255,89 260,11 +0,24% 1,65% 2.576.700
07/01/2022 259,74 261,25 256,71 259,50 +0,07% 1,75% 2.245.100
06/01/2022 260,10 261,30 255,46 259,33 -0,51% 2,25% 2.863.200
05/01/2022 268,16 268,77 260,42 260,65 -2,31% 3,11% 3.004.200
04/01/2022 269,00 269,88 263,58 266,81 -1,81% 2,34% 2.340.500
03/01/2022 274,41 274,41 267,06 271,73 -1,63% 2,68% 2.621.300
31/12/2021 277,47 278,73 276,01 276,22 -0,37% 0,98% 1.315.700
30/12/2021 279,19 280,65 276,37 277,25 -0,42% 1,53% 1.181.500
29/12/2021 275,82 279,36 275,74 278,42 +0,72% 1,31% 1.112.300
28/12/2021 279,34 279,40 275,89 276,43 -0,71% 1,26% 1.033.900
27/12/2021 275,04 280,30 274,72 278,41 +1,94% 2,03% 1.677.100
23/12/2021 269,05 275,27 266,68 273,10 +2,48% 3,19% 2.632.200
22/12/2021 264,74 266,56 262,85 266,50 +0,61% 1,40% 2.721.000
21/12/2021 264,00 265,95 260,57 264,88 +0,53% 2,04% 2.702.500
20/12/2021 269,23 270,01 260,35 263,48 -1,47% 3,59% 3.479.400
17/12/2021 276,67 276,67 265,33 267,42 -4,16% 4,10% 7.582.900
16/12/2021 275,67 283,90 272,05 279,04 +1,37% 4,30% 5.546.400
15/12/2021 262,07 275,54 257,21 275,28 +10,39% 6,99% 10.016.700
14/12/2021 247,74 250,01 246,39 249,38 +0,34% 1,46% 3.424.000
13/12/2021 245,51 250,70 245,46 248,53 +1,80% 2,13% 3.016.700
10/12/2021 241,20 244,59 241,20 244,14 +0,51% 1,41% 2.380.800
09/12/2021 244,49 245,91 242,75 242,90 -0,58% 1,29% 2.291.100